BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22857015)

  • 1. Intensity modulated radiotherapy in early stage Hodgkin lymphoma patients: is it better than three dimensional conformal radiotherapy?
    De Sanctis V; Bolzan C; D'Arienzo M; Bracci S; Fanelli A; Cox MC; Valeriani M; Osti MF; Minniti G; Chiacchiararelli L; Enrici RM
    Radiat Oncol; 2012 Aug; 7():129. PubMed ID: 22857015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiotherapy for early mediastinal Hodgkin lymphoma according to the German Hodgkin Study Group (GHSG): the roles of intensity-modulated radiotherapy and involved-node radiotherapy.
    Koeck J; Abo-Madyan Y; Lohr F; Stieler F; Kriz J; Mueller RP; Wenz F; Eich HT
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):268-76. PubMed ID: 22079733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consolidative involved-node proton therapy for Stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a Phase II study.
    Hoppe BS; Flampouri S; Su Z; Morris CG; Latif N; Dang NH; Lynch J; Li Z; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):260-7. PubMed ID: 22014950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of heart and coronary artery doses associated with intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for distal esophageal cancer.
    Kole TP; Aghayere O; Kwah J; Yorke ED; Goodman KA
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1580-6. PubMed ID: 22284687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different IMRT solutions vs. 3D-conformal radiotherapy in early stage Hodgkin's Lymphoma: dosimetric comparison and clinical considerations.
    Fiandra C; Filippi AR; Catuzzo P; Botticella A; Ciammella P; Franco P; Borca VC; Ragona R; Tofani S; Ricardi U
    Radiat Oncol; 2012 Nov; 7():186. PubMed ID: 23122028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dosimetry study precisely outlining the heart substructure of left breast cancer patients using intensity-modulated radiation therapy.
    Fan LL; Luo YK; Xu JH; He L; Wang J; Du XB
    J Appl Clin Med Phys; 2014 Sep; 15(5):4624. PubMed ID: 25207559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anterior myocardial territory may replace the heart as organ at risk in intensity-modulated radiotherapy for left-sided breast cancer.
    Tan W; Liu D; Xue C; Xu J; Li B; Chen Z; Hu D; Wang X
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1689-97. PubMed ID: 21621342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetric advantages of a "butterfly" technique for intensity-modulated radiation therapy for young female patients with mediastinal Hodgkin's lymphoma.
    Voong KR; McSpadden K; Pinnix CC; Shihadeh F; Reed V; Salehpour MR; Arzu I; Wang H; Hodgson D; Garcia J; Aristophanous M; Dabaja BS
    Radiat Oncol; 2014 Apr; 9():94. PubMed ID: 24735767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is intensity-modulated radiotherapy better than conventional radiation treatment and three-dimensional conformal radiotherapy for mediastinal masses in patients with Hodgkin's disease, and is there a role for beam orientation optimization and dose constraints assigned to virtual volumes?
    Girinsky T; Pichenot C; Beaudre A; Ghalibafian M; Lefkopoulos D
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):218-26. PubMed ID: 16169675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Volumetric-modulated arc therapy vs. c-IMRT in esophageal cancer: a treatment planning comparison.
    Yin L; Wu H; Gong J; Geng JH; Jiang F; Shi AH; Yu R; Li YH; Han SK; Xu B; Zhu GY
    World J Gastroenterol; 2012 Oct; 18(37):5266-75. PubMed ID: 23066322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IMRT and 3D conformal radiotherapy with or without elective nodal irradiation in locally advanced NSCLC: A direct comparison of PET-based treatment planning.
    Fleckenstein J; Kremp K; Kremp S; Palm J; RĂ¼be C
    Strahlenther Onkol; 2016 Feb; 192(2):75-82. PubMed ID: 26438071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of 3D-CRT, IMRT and VMAT radiotherapy plans for left breast cancer based on clinical dosimetric study.
    Liu H; Chen X; He Z; Li J
    Comput Med Imaging Graph; 2016 Dec; 54():1-5. PubMed ID: 27838084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left breast irradiation with tangential intensity modulated radiotherapy (t-IMRT) versus tangential volumetric modulated arc therapy (t-VMAT): trade-offs between secondary cancer induction risk and optimal target coverage.
    Karpf D; Sakka M; Metzger M; Grabenbauer GG
    Radiat Oncol; 2019 Sep; 14(1):156. PubMed ID: 31477165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric comparison of intensity-modulated radiotherapy plans, with or without anterior myocardial territory and left ventricle as organs at risk, in early-stage left-sided breast cancer patients.
    Tan W; Wang X; Qiu D; Liu D; Jia S; Zeng F; Chen Z; Li B; Xu J; Wei L; Hu D
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1544-51. PubMed ID: 21470785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Volumetric modulation arc radiotherapy with flattening filter-free beams compared with static gantry IMRT and 3D conformal radiotherapy for advanced esophageal cancer: a feasibility study.
    Nicolini G; Ghosh-Laskar S; Shrivastava SK; Banerjee S; Chaudhary S; Agarwal JP; Munshi A; Clivio A; Fogliata A; Mancosu P; Vanetti E; Cozzi L
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):553-60. PubMed ID: 22386376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimising contralateral breast dose in post-mastectomy intensity-modulated radiotherapy by incorporating conformal electron irradiation.
    van der Laan HP; Korevaar EW; Dolsma WV; Maduro JH; Langendijk JA
    Radiother Oncol; 2010 Feb; 94(2):235-40. PubMed ID: 20080312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicted risk of radiation-induced cancers after involved field and involved node radiotherapy with or without intensity modulation for early-stage hodgkin lymphoma in female patients.
    Weber DC; Johanson S; Peguret N; Cozzi L; Olsen DR
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):490-7. PubMed ID: 20800383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dose distributions of proton beam therapy for hepatocellular carcinoma: a comparative study of treatment planning with 3D-conformal radiation therapy or intensity-modulated radiation therapy].
    Li JM; Yu JM; Liu SW; Chen Q; Mu XK; Jiang QA; Zhao MH; Zhang JG
    Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(45):3201-6. PubMed ID: 20193534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involved-node and involved-field volumetric modulated arc vs. fixed beam intensity-modulated radiotherapy for female patients with early-stage supra-diaphragmatic Hodgkin lymphoma: a comparative planning study.
    Weber DC; Peguret N; Dipasquale G; Cozzi L
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1578-86. PubMed ID: 19596171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abdominal DIBH reduces the cardiac dose even further: a prospective analysis.
    Zhao F; Shen J; Lu Z; Luo Y; Yao G; Bu L; Ge J; Yang X; Ning L; Yan S
    Radiat Oncol; 2018 Jun; 13(1):116. PubMed ID: 29929560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.